Human PTHrP-(1-36)

Modify Date: 2024-01-21 11:35:53

Human PTHrP-(1-36) Structure
Human PTHrP-(1-36) structure
Common Name Human PTHrP-(1-36)
CAS Number 172867-62-8 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Human PTHrP-(1-36)


Human PTHrP-(1-36) is a secretory form of PTHrP with anticalciuric effects. Human PTHrP-(1-36) enhances beta cell function and proliferation. Human PTHrP-(1-36) can be used in the research of humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism[1][3].

 Names

Name Human PTHrP-(1-36)

 Human PTHrP-(1-36) Biological Activity

Description Human PTHrP-(1-36) is a secretory form of PTHrP with anticalciuric effects. Human PTHrP-(1-36) enhances beta cell function and proliferation. Human PTHrP-(1-36) can be used in the research of humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism[1][3].
Related Catalog
In Vitro Human PTHrP-(1-36) (EC50: 0.05 nM) increases intracellular calcium in human epidermal keratinocytes[2]. Human PTHrP-(1-36) (100 nM, 24 h) increases human β-cell proliferation[3]. Human PTHrP-(1-36) (100 nM, 30 min) enhances insulin secretion in human islets[3]. PTHrP-(1-36) (mouse, EC50: 1 nM) induces a rapid Ca2+ response in UMR 106 cells[4].
In Vivo PTHrP-(1-36) (mouse, 160 μg/kg, s.c., for 5 days/week for 7, 30, or 90 days) enhances beta cell regeneration and increases beta cell mass in a mouse model of partial pancreatectomy[5]. PTHrP-(1-36) (mouse, 100 μg/kg, s.c., every other day) reverses the observed decrease of Wisp1 expression in the diabetic mice[6].

 Chemical & Physical Properties

No Any Chemical & Physical Properties